Gene delivery of immunomodulatory cytokines to the lung preserves respiratory function during inflammatory challenge
Authors:
- Ntombizodwa MakuyanaNMNtombizodwa Makuyana
- Laura SeldeslachtsLSLaura Seldeslachts
- Lauren MichielsLMLauren Michiels
- Oliver T. BurtonOBOliver T. Burton
- Alvaro R. HernandezAHAlvaro R. Hernandez
- Arman GhodsiniaAGArman Ghodsinia
- Ekhlas RahmanEREkhlas Rahman
- Laura M. KopsLKLaura M. Kops
- Kailash SinghKSKailash Singh
- Magda AliMAMagda Ali
- Amy DashwoodADAmy Dashwood
- 17 April 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (118) , eadv7969
Abstract
Respiratory infections that result in severe and life-threatening immune-mediated respiratory decline are a major public health issue. Controlling local respiratory immune reactions without the use of systemic immunosuppressants remains an unmet clinical challenge. We developed a gene delivery system to express anti-inflammatory cytokines in the lung, which reestablishes local immune homeostasis without triggering systemic effects. Using an adeno-associated vector cargo system (AAV6.2- CC10 ), we induced production of interleukin-2 (IL-2), IL-1 receptor antagonist (IL-1RA), and IL-10 in situ in the lung microenvironment, with no detectable expression or immunological deviation in the peripheral immune system. We demonstrate the effective potential of IL-2, IL-1RA, and IL-10 as immunomodulatory cargos in severe infectious challenge, which reduced respiratory pathology after influenza-associated pulmonary aspergillosis. Thus, the AAV6.2- CC10 platform enables targeted delivery of biologics to the lung, modulates the lung environment, and improves pathology without inducing systemic immune reactions.Keywords
Funding Information
- Wellcome Trust (222442/A/21/Z)
- Wellcome Trust (227236/Z/23/Z)
- H2020 European Research Council (MSCA-IF REP-893236-1)
- Fonds Wetenschappelijk Onderzoek (1199825N)
- Gates Cambridge Trust (OPP1144)
- Wallonie-Bruxelles International (SUB/2021/513056)
- Vlaamse regering (G053121N)
- Vlaamse regering (1186121N/1186123)
- Vlaamse regering (PDMT2/24/075)
- Junior Postdoctoral Mandate (1266926N)
This publication has 77 references indexed in Scilit:
- A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosisJournal of Neurology, 2023
- Do more with Less: Improving High Parameter Cytometry Through Overnight StainingCurrent Protocols, 2022
- OMIP‐059: Identification of Mouse Hematopoietic Stem and Progenitor Cells with Simultaneous Detection of CD45.1/2 and Controllable Green Fluorescent Protein Expression by a Single Staining PanelCytometry Part A, 2019
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- IL-1Ra and its Delivery Strategies: Inserting the Association in PerspectivePharmaceutical Research, 2013
- Faithful activation of an extra‐bright red fluorescent protein in “knock‐in” Cre‐reporter mice ideally suited for lineage tracing studiesEuropean Journal of Immunology, 2006
- Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in ratsBrain Research, 1995
- The mouse interleukin 1 receptor antagonist protein: gene structure and regulation in vitroCytokine, 1994
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Proliferation of respiratory tract epithelium in the ratExperimental Cell Research, 1967